Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
eli lilly
3
×
genentech
3
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
avapritinib
blueprint medicines
boston
clinical trials
fda
indiana blog main
indiana top stories
medullary thyroid cancer
non-small cell lung cancer
novartis
pralsetinib
roche
selpercatinib
thyroid cancer
10x genomics
abbvie
allergan
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avexis
biogen
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
What
fda
approval
blueprint
cancer
drug
medicines
regulatory
ret
address
approves
august
bio
biotech
busy
candidate
carries
certain
currently
days
decisions
designed
devices
drugs
genetic
latest
legacy
marketing
muscle
news
nods
opioid
pact
pass
past
review
roche
roundup
sarepta’s
seven
shkreli’s
Language
unset
3
×
Current search:
genentech
×
" eli lilly "
×
unset
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More